Detalhe da pesquisa
1.
Efficacy and safety of golimumab in patients with non-radiographic axial spondyloarthritis: a withdrawal and retreatment study (GO-BACK).
Rheumatology (Oxford)
; 62(11): 3601-3609, 2023 11 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36919768
2.
Partial remission in ankylosing spondylitis and non-radiographic axial spondyloarthritis in treatment with infliximab plus naproxen or naproxen alone: associations between partial remission and baseline disease characteristics.
Rheumatology (Oxford)
; 55(11): 1946-1953, 2016 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-27411482
3.
Factors influencing the patient evaluation of injection experience with the SmartJect autoinjector in rheumatoid arthritis.
Clin Exp Rheumatol
; 33(2): 201-8, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25664404
4.
Efficacy and safety of golimumab as add-on therapy to disease-modifying antirheumatic drugs: results of the GO-MORE study.
Ann Rheum Dis
; 73(8): 1477-86, 2014 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-23740226
5.
Efficacy and safety of timothy grass allergy immunotherapy tablets in North American children and adolescents.
J Allergy Clin Immunol
; 127(1): 64-71, 71.e1-4, 2011 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-21211642
6.
Colectomy Incidence Rates in Five-Year Data From the Observational Postmarketing Ulcerative Colitis Study of Originator Infliximab.
Inflamm Bowel Dis
; 27(12): 1963-1967, 2021 11 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33577644
7.
Continuous Clinical Response Is Associated With a Change of Disease Course in Patients With Moderate to Severe Ulcerative Colitis Treated With Golimumab.
Inflamm Bowel Dis
; 25(1): 163-171, 2019 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29982631
8.
Five-year Safety Data From OPUS, a European Observational Safety Registry for Adults With Ulcerative Colitis Treated With Originator Infliximab [Remicade®] or Conventional Therapy.
J Crohns Colitis
; 13(9): 1148-1157, 2019 Sep 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-30809631
9.
Efficacy and safety of golimumab in Indian patients with rheumatoid arthritis: Subgroup data from GO-MORE study.
Int J Rheum Dis
; 19(11): 1083-1092, 2016 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-27457311
10.
Patient and physician expectations of add-on treatment with golimumab for rheumatoid arthritis: relationships between expectations and clinical and quality of life outcomes.
Arthritis Care Res (Hoboken)
; 66(12): 1799-807, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-24839031
11.
Effects of mometasone, fluticasone, and montelukast on bone mineral density in adults with asthma.
J Allergy Clin Immunol Pract
; 1(6): 649-55.e1, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-24565713
12.
Efficacy and safety of fixed-dose loratadine/montelukast in seasonal allergic rhinitis: effects on nasal congestion.
Allergy Asthma Proc
; 30(3): 263-9, 2009.
Artigo
em Inglês
| MEDLINE | ID: mdl-19549427
13.
Efficacy of loratadine-montelukast on nasal congestion in patients with seasonal allergic rhinitis in an environmental exposure unit.
Ann Allergy Asthma Immunol
; 102(4): 328-38, 2009 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-19441605
14.
Onset of action of loratadine/montelukast in seasonal allergic rhinitis subjects exposed to ragweed pollen in the Environmental Exposure Unit.
Allergy Asthma Proc
; 30(3): 270-6, 2009.
Artigo
em Inglês
| MEDLINE | ID: mdl-19549428
15.
A placebo-controlled study of the nasal decongestant effect of phenylephrine and pseudoephedrine in the Vienna Challenge Chamber.
Ann Allergy Asthma Immunol
; 102(2): 116-20, 2009 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-19230461